Barlow St-Clair Lynch, M.D.; Decision and Order
DEA revoked Dr. Barlow St-Clair Lynch's registration to prescribe controlled substances due to violations. Pharmacies must verify prescriber status before filling controlled substance prescriptions.
Aforeworn detected this change in the Pharmacy & Controlled Substances space on July 16, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated High urgency. Pharmacies filling controlled substance prescriptions from Dr. Lynch or any prescriber with revoked DEA registration should confirm how it applies to their specific situation before acting. There is a time constraint attached: Immediately; ongoing compliance required.. Acting after that point can mean penalties, a lapsed licence, or lost eligibility — exactly the kind of surprise Aforeworn exists to prevent. Aforeworn monitors Pharmacy & Controlled Substances continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.
What changed
Dr. Lynch's DEA registration is revoked; any prescriptions issued by him after the revocation date are invalid.
Who it affects
Pharmacies filling controlled substance prescriptions from Dr. Lynch or any prescriber with revoked DEA registration
What you must do
Check DEA registration status of all prescribers before dispensing controlled substances; reject prescriptions from revoked prescribers.
Deadline
Immediately; ongoing compliance required.
Never miss a change like this again
Aforeworn watches Pharmacy & Controlled Substances around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.
Start your free trialRelated changes in Pharmacy & Controlled Substances
- TX HB 7: Relating to prohibitions on the manufacture and provision of abortion-inducing drugs, including the jurisdiction of and effect of certain judgments by courts within and outside this state with respect to the manufacture and provision of those drugs, and to protections from certain counteractions under the laws of other states and jurisdictions; authorizing qui tam actions.
- US-CONGRESS HR7895: PBM Kickback Prohibition Act
- IL HB0004: MEDICAID-PHARMACY SERVICES
- Drugs for Human Use; Drug Efficacy Study Implementation: Estrogen-Androgen Fixed-Combination Drug Products; Extension of Effective Date of Final Resolution of Drug Efficacy Study Implementation 7661
- Endo Operations Limited, et al.; Withdrawal of Approval of 34 New Drug Applications